3/15
11:02 pm
plx
Protalix BioTherapeutics, Inc. (NYSE: PLX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Medium
Report
Protalix BioTherapeutics, Inc. (NYSE: PLX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
3/15
01:30 pm
plx
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/14
06:56 am
plx
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results [Yahoo! Finance]
Medium
Report
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results [Yahoo! Finance]
3/14
06:50 am
plx
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results
Medium
Report
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results
3/7
07:03 am
plx
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024 [Yahoo! Finance]
Low
Report
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024 [Yahoo! Finance]
3/7
06:50 am
plx
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024
Low
Report
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024
2/23
07:01 am
plx
Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference [Yahoo! Finance]
Low
Report
Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference [Yahoo! Finance]
2/23
06:50 am
plx
Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference
Low
Report
Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference